Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E17.47 EPS (ttm)5.59 Insider Own0.01% Shs Outstand2.77B Perf Week-2.41%
Market Cap270.87B Forward P/E15.21 EPS next Y6.42 Insider Trans-51.97% Shs Float2.77B Perf Month-2.46%
Income15.92B PEG3.41 EPS next Q1.69 Inst Own67.40% Short Float1.13% Perf Quarter-3.11%
Sales73.59B P/S3.68 EPS this Y18.50% Inst Trans-0.33% Short Ratio4.12 Perf Half Y-5.69%
Book/sh24.39 P/B4.00 EPS next Y4.61% ROA15.70% Target Price109.59 Perf Year-4.37%
Cash/sh11.29 P/C8.65 EPS next 5Y5.13% ROE28.30% 52W Range93.15 - 107.45 Perf YTD-5.25%
Dividend3.00 P/FCF45.56 EPS past 5Y5.30% ROI18.40% 52W High-9.34% Beta0.56
Dividend %3.07% Quick Ratio2.10 Sales past 5Y3.70% Gross Margin69.30% 52W Low4.57% ATR1.10
Employees126500 Current Ratio2.40 Sales Q/Q-4.10% Oper. Margin28.80% RSI (14)39.32 Volatility1.03% 1.04%
OptionableYes Debt/Eq0.28 EPS Q/Q-6.70% Profit Margin28.10% Rel Volume1.02 Prev Close97.68
ShortableYes LT Debt/Eq0.22 EarningsJul 14 BMO Payout38.10% Avg Volume7.63M Price97.41
Recom2.50 SMA20-1.65% SMA50-2.43% SMA200-4.05% Volume3,706,208 Change-0.28%
May-21-15Reiterated Deutsche Bank Hold $106 → $110
Dec-08-14Reiterated RBC Capital Mkts Outperform $110 → $114
Jul-16-14Reiterated Deutsche Bank Hold $102 → $107
Apr-17-14Reiterated Argus Buy $104 → $116
Apr-16-14Reiterated RBC Capital Mkts Outperform $104 → $106
Jan-10-14Downgrade Barclays Overweight → Equal Weight $99
Jan-07-14Upgrade RBC Capital Mkts Sector Perform → Outperform $88 → $104
Dec-16-13Reiterated Deutsche Bank Hold $93 → $95
Jul-18-13Reiterated Argus Buy $96 → $104
Jul-17-13Reiterated Barclays Overweight $95 → $99
Jul-17-13Downgrade Deutsche Bank Buy → Hold $92 → $93
Apr-18-13Reiterated Argus Buy $80 → $96
Apr-15-13Reiterated Barclays Overweight $85 → $95
Apr-12-13Reiterated Deutsche Bank Buy $82 → $87
Mar-26-13Reiterated UBS Buy $81 → $87
Jan-11-13Reiterated UBS Buy $76 → $78
Jan-04-13Upgrade Deutsche Bank Hold → Buy $75 → $82
Nov-20-12Initiated Stifel Nicolaus Hold
Jul-18-12Reiterated RBC Capital Mkts Sector Perform $65 → $71
Apr-18-12Reiterated UBS Buy $71 → $70
Jun-29-15 07:52PM  Contact lens companies say Utah law hurts their business
03:22PM  Greece crisis hits shares of some, but not all, U.S. multinationals
08:07AM  Better Dividend Stock: AbbVie or Johnson & Johnson? at Motley Fool
Jun-26-15 06:17PM  Even your favorite brands dont really know you at MarketWatch
08:03AM  Why This Small Cap Biotech Stock Is Becoming One of My Favorites at Motley Fool
Jun-25-15 11:50AM  The six best sectors for 2015s second half at MarketWatch
Jun-24-15 06:10AM  Hope And Hype For New Type Of Antidepressant at Forbes
Jun-23-15 11:06PM  Could ASCO's New Ratings Boost J&J's Sales? at Investopedia
11:18AM  Will the ad industrys new Sheryl Sandberg-backed award go far enough on gender equality? at Fortune
Jun-22-15 05:13PM  Bruker CEO's $20M Stock Buy at Barrons.com
Jun-19-15 09:00PM  10 Dream Mergers; Fed's Greek Problem; Up Side of Negativity: Jim Cramer's Best Blogs at TheStreet
03:46PM  Business of bacteria
01:36PM  This will change the face of human health: Pro
08:33AM  Microbiome studies changing human health
Jun-18-15 06:48PM  Dividend ETFs Could Lag If Interest Rates Rise at Investor's Business Daily
04:01PM  The 4 Stocks That Dominated the DJIA on Thursday at 24/7 Wall St.
01:30PM  This Dow Stock Is A Dividend Machine
01:17PM  Economy will continue to accelerate: Pro
07:05AM  Wyss Institutes organs-on-chips to be used in drug research at J&J at bizjournals.com
Jun-17-15 05:43PM  How High Could Johnson & Johnson's Dividend Go? at Investopedia
12:40PM  Impax's Zomig Nasal Spray Gets FDA Nod for Pediatrics - Analyst Blog
08:00AM  Johnson & Johnson Heading for Another Rally at TheStreet
07:45AM  Bert Vogelstein, M.D., Wins 2015 Dr. Paul Janssen Award for Biomedical Research PR Newswire
Jun-16-15 06:37PM  Ray Dalio Indicator Tells You To Avoid Apple Inc. (AAPL), Johnson & Johnson (JNJ) and Potash at Insider Monkey
06:00PM  Cramer dreams of takeovers
04:07PM  Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results PR Newswire
Jun-13-15 03:34AM  Discount contact lens retailers given OK to lower prices
Jun-12-15 11:21PM  Court allows hotly disputed discount contact lens price law
08:40PM  Court allows contested contact lens price-fixing law
04:21PM  Obamas Pacific trade deal will help these sectors if it passes at MarketWatch
10:10AM  Stock Market News for June 12, 2015 - Market News
Jun-11-15 12:58PM  Isis, Biogen Rare-Disease Drug Aids Infant Survival at Investor's Business Daily
11:45AM  S&P 500 Index Futures Trading Higher
11:21AM  Johnson and Johnson CEO: Cancer Research Is Paying Off at Fox Business
08:39AM  Johnson & Johnson starts project to prevent Type 1 diabetes
Jun-10-15 08:10PM  Is This Johnson & Johnson's Next Blockbuster? at Investopedia
06:57PM  Ghana halts Ebola vaccine trial due to community protests Reuters
11:33AM  The 7 Best CEOs of Huge Consumer Companies at TheStreet
10:06AM  How to Trade the Stocks of Four Giants in the Health Care Industry at TheStreet
Jun-09-15 06:00PM  Drug switch study bolsters case for copies of biotech medicine
05:11PM  JOHNSON & JOHNSON Files SEC form 8-K, Change in Directors or Principal Officers
04:30PM  CEO and Director of Huntsman Cancer Institute Dr. Mary Beckerle Joins Johnson & Johnson Board of Directors PR Newswire
Jun-08-15 06:24PM  J&J Initiates Filing for Multiple Myeloma Drug - Analyst Blog
02:03PM  This Technology Could Disrupt U.S. Pharma Stocks, Credit Suisse Says
01:35PM  Cardinal Health to Buy The Harvard Drug Group for $1.12B - Analyst Blog
01:00PM  Autoimmune Drugs to Drive Big Pharma Higher in Coming Years at 24/7 Wall St.
10:47AM  S&P 500 Index Futures Trading Lower In Choppy Session
10:30AM  Dont Forget This Healthcare ETF
08:47AM  Genmab shares rise on cancer drug's FDA licence application Reuters
01:00AM  JNJ, MMM, PVH, HD: Jim Cramer's Views at TheStreet
Jun-05-15 11:26PM  Cardinal Health To Buy Generics Distributor Harvard Drug Group at The Wall Street Journal
03:15PM  AbbVie Reports Positive Results on Oncology Drug Imbruvica - Analyst Blog
02:53PM  Now is not the time for Johnson & Johnson at MarketWatch
02:24PM  Cardinal Health To Buy Generics Distributor at The Wall Street Journal
10:50AM  Cardinal Health paying $1.1B for pharmaceutical distributor
09:53AM  Cardinal Health to spend $1.1B on drug distributor
08:00AM  Johnson & Johnson Goes Back to Campus for New Hires at The Wall Street Journal
Jun-04-15 06:19PM  SEC Gets Statistical In Search For Median Employee's Pay at The Wall Street Journal
11:58AM  2015 Global 2000: The World's Largest Drug And Biotech Companies at Forbes
Jun-03-15 03:10PM  The 15 best retail companies to work for in America Business Insider
08:30AM  Are shareholders 'lazy'?
Jun-02-15 07:33PM  Could Johnson & Johnson Divest More Assets? at Investopedia
04:00PM  [video]Why Health Care Stocks Will Continue to Lead Market Higher at TheStreet
10:45AM  5 Stocks That Warren Buffett Should Sell or Add to the Stake at 24/7 Wall St.
08:00AM  Being a Clever Investor Isn't Always Smart at Kiplinger
Jun-01-15 02:20PM  AbbVie Presents Positive Data from Multiple Studies at ASCO - Analyst Blog
09:00AM  Pharmalot.. Pharmalittle.. Good Morning: We're Catching up on ASCO, Bristol-Myers and Lots More!! at The Wall Street Journal
08:46AM  June 1 Premarket Briefing: 10 Things You Should Know
08:30AM  Johnson & Johnson And The 9 Other Stocks Baby Boomers Love Most at Forbes
May-31-15 05:17PM  Billionaire Cliff Asness Long Term Holdings at Insider Monkey
May-30-15 07:35AM  ASCO '15: J&J Antibody Benefits Patients With Hardest-to-Treat Multiple Myeloma at TheStreet
07:30AM  J&J multiple myeloma drug offers hope after others stop working -study
May-29-15 11:51AM  This stock is no longer in the Top 20 most held at CNBC
08:19AM  1 Positive, 1 Negative For Johnson & Johnson Stock
May-28-15 07:32PM  Will Gilead's Hepatitis C Dominance Collapse? at Investopedia
06:53PM  Which Dividend ETFs Provide Steadiest Income? at Investor's Business Daily
06:15PM  J&J accepts offer from Cardinal Health for Cordis unit at Los Angeles Times
09:33AM  Stocks to Watch: Abercrombie & Fitch, Avago Technologies, J&J at The Wall Street Journal
08:50AM  J&J accepts offer from Cardinal Health for Cordis unit
08:26AM  [$$] J&J Accepts Cardinal Health Offer for Heart Business at The Wall Street Journal
08:00AM  Johnson & Johnson Announces Acceptance of Binding Offer From Cardinal Health To Acquire Cordis PR Newswire
12:30AM  FBI Is Investigating Hysterectomy Device Found to Spread Uterine Cancer at The Wall Street Journal
May-27-15 08:14PM  Johnson & Johnson's 3 Most Important Numbers at Investopedia
02:34PM  FBI probing what J&J knew about uterine surgery device - WSJ Reuters
02:30PM  US not thinking about extending nuclear talks
01:54PM  FBI Probes J&J Over Hysterectomy Device at The Wall Street Journal
01:28PM  Utah defends contentious law on contact lens price-fixing
12:57PM  Gilead-GlobeImmune Hepatitis B Drug Fails Trial at Investor's Business Daily
12:17PM  How Law Firms Use Facebook and Other Data to Track Down Medical Victims at Bloomberg
12:17PM  How Law Firms Use Facebook and Other Data to Track Down Medical Victims
12:05PM  3 High-Yield, Low-Risk Dividend Stocks for Extreme Safety at TheStreet
12:02PM  How to Use Options to Profit From Johnson & Johnson's Success at TheStreet
09:30AM  Johnson & Johnson to Participate in the Goldman Sachs 36th Annual Global Healthcare Conference PR Newswire
May-26-15 02:27PM  Jim Cramer -- Here's Why I'm Buy, Buy, Buying J&J and Selling Merck at TheStreet
12:34PM  Cramer: I'm Buying J&J as It Has the Most Upside of Major Pharmas at TheStreet
11:15AM  Abbvie completes $21 billion buyout of Pharmacyclics
09:30AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, AstraZeneca, ACADIA Pharmaceuticals, Actavis and Alkermes - Press Releases
01:48AM  Pharma Trumps All Healthcare Sectors In Executive Compensation at Forbes
May-25-15 08:02AM  Considering the Investment Impact of Baby Boomers Retirement
May-22-15 08:20PM  Johnson & Johnson Seeks to Deliver 10 Blockbusters at Investopedia
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women's health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages and first aid products under the BAND-AID and NEOSPORIN brand names; and nutritional products comprising no calorie sweetener under the SPLENDA brand name. This segment also offers over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic, and trauma and neurological products; general surgery, and biosurgical and energy products; products to treat cardiovascular disease; infection prevention products; diagnostics products; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company distributes its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PRINCE CHARLESDirectorJun 02Buy99.222,500248,05023,145Jun 03 05:20 PM
Stoffels PaulusChief Scientific OfficerApr 28Option Exercise64.43228,68314,733,404281,723Apr 30 04:56 PM
Stoffels PaulusChief Scientific OfficerApr 28Sale100.73187,25018,862,14294,473Apr 30 04:56 PM
Fasolo PeterVP, Global Human ResourcesMar 05Option Exercise65.37115,3077,537,619147,895Mar 09 05:14 PM
Fasolo PeterVP, Global Human ResourcesMar 05Sale102.40115,30711,807,86332,588Mar 09 05:14 PM
Stoffels PaulusChief Scientific OfficerFeb 09Option Exercise0.0029,073064,647Feb 11 08:16 PM
Caruso Dominic JVP, Finance; CFOFeb 09Option Exercise0.0031,5370101,324Feb 11 08:16 PM
Fasolo PeterVP, Global Human ResourcesFeb 09Option Exercise0.0020,935042,109Feb 11 08:16 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0042,1120130,173Feb 11 08:17 PM
COSGROVE STEPHEN JCorporate ControllerJan 16Option Exercise0.0011,1080101,402Jan 21 05:48 PM
Ullmann Michael HVP, General CounselJan 16Option Exercise0.008,949075,628Jan 21 05:48 PM
Caruso Dominic JVP, Finance; CFOJan 16Option Exercise0.0012,615074,216Jan 21 05:48 PM
Gorsky AlexChairman, CEOJan 16Option Exercise0.0016,845094,425Jan 21 05:48 PM
Stoffels PaulusChief Scientific OfficerJan 16Option Exercise0.0011,629039,539Jan 21 05:48 PM
Fasolo PeterVP, Global Human ResourcesJan 16Option Exercise0.008,374024,336Jan 21 05:48 PM
PETERSON SANDRA EGroup Worldwide ChairmanDec 17Option Exercise0.0021,689031,210Dec 19 04:37 PM
JOHNSON & JOHNSON10% OwnerNov 12Buy18.0040,000720,0003,077,005Nov 12 03:06 PM
COSGROVE STEPHEN JCorporate ControllerNov 05Option Exercise66.182,490164,78892,784Nov 07 04:49 PM
COSGROVE STEPHEN JCorporate ControllerNov 05Sale108.552,490270,29390,294Nov 07 04:49 PM
CULLEN JAMESDirectorSep 10Sale104.122,446254,6721,489Sep 11 02:19 PM
Caruso Dominic JVP, Finance; CFOAug 21Option Exercise66.1830,0001,985,40091,600Aug 25 04:35 PM
Caruso Dominic JVP, Finance; CFOAug 21Sale104.3030,0003,129,06961,600Aug 25 04:35 PM